Ann: Positive feedback received on Paediatric Investigation Plan, page-203

@V8 just go to the official news releases of Sarepta related to the 500 mio usd raise...

could all just be a huge coincidence, but the timing and the amount are admittedly suspicious. Their trial on DMD failed recently and they are under a lot of pressure. ANP recent DMD data have been very good and exactly what they actually needed.
Sarepta still have 1,5 billion in cash, but it does make sense for them not to spend that (since they are still making losses) and to keep that in the war chest.
ANP is the easy and obvious solution for them.

in addition there are close ties of ANP and Sarepta management.

that quickly sums up all the speculation.